Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidekazu Shirota

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cancer Science|May 11, 2023
Human resources for administrative work to carry out a comprehensive genomic profiling test in JapanHidenori Kage, Katsutoshi Oda, Manabu Muto, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2021
Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkersMasanobu Takahashi, Yasuhiro Sakamoto, Hisatsugu Ohori, et al.
Medicine|August 10, 2020
A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)Kenta Takahashi, Eri Ishibashi, Toshio Kubo, et al.
JCO Precision Oncology|April 23, 2026
Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling PathwayKen Saijo, Hiroo Imai, Tomoyuki Iwasaki, et al.
Scientific Reports|July 7, 2026
Clinical utility of comprehensive genomic profiling tests using MTB management system at a single center in JapanChie Sarudate, Miki Dobashi, Maako Kawamura, et al.
Journal of Autoimmunity|March 4, 2014
IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in miceDeborah L Hodge, Cyril Berthet, Vincenzo Coppola, et al.
Cancer Science|January 26, 2024
Patient survey on cancer genomic medicine in Japan under the national health insurance systemHidenori Kage, Nana Akiyama, Hyangri Chang, et al.
JAMA Network Open|December 5, 2022
Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in JapanYoichi Naito, Kuniko Sunami, Hidenori Kage, et al.
Cancer Medicine|April 18, 2025
Regional Differences in the Frequency of BRCA1 and BRCA2 Variants in Northeastern Japan: A Cohort StudyHidekazu Shirota, Akimitsu Miyake, Maako Kawamura, et al.
Clinical and Translational Science|June 14, 2025
Evaluation of Organoid-Derived Exosomal microRNA as Liquid Biopsy for Colorectal Cancer: A Multicenter Cross-Sectional StudyAtsuhiro Sasaki, Masatake Kuroha, Masaki Tosa, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancer Science|May 11, 2023
Human resources for administrative work to carry out a comprehensive genomic profiling test in JapanHidenori Kage, Katsutoshi Oda, Manabu Muto, et al.
Cancer Chemotherapy and Pharmacology|May 24, 2021
Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkersMasanobu Takahashi, Yasuhiro Sakamoto, Hisatsugu Ohori, et al.
Medicine|August 10, 2020
A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)Kenta Takahashi, Eri Ishibashi, Toshio Kubo, et al.
JCO Precision Oncology|April 23, 2026
Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling PathwayKen Saijo, Hiroo Imai, Tomoyuki Iwasaki, et al.
Scientific Reports|July 7, 2026
Clinical utility of comprehensive genomic profiling tests using MTB management system at a single center in JapanChie Sarudate, Miki Dobashi, Maako Kawamura, et al.
Journal of Autoimmunity|March 4, 2014
IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in miceDeborah L Hodge, Cyril Berthet, Vincenzo Coppola, et al.
Cancer Science|January 26, 2024
Patient survey on cancer genomic medicine in Japan under the national health insurance systemHidenori Kage, Nana Akiyama, Hyangri Chang, et al.
JAMA Network Open|December 5, 2022
Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in JapanYoichi Naito, Kuniko Sunami, Hidenori Kage, et al.
Cancer Medicine|April 18, 2025
Regional Differences in the Frequency of BRCA1 and BRCA2 Variants in Northeastern Japan: A Cohort StudyHidekazu Shirota, Akimitsu Miyake, Maako Kawamura, et al.
Clinical and Translational Science|June 14, 2025
Evaluation of Organoid-Derived Exosomal microRNA as Liquid Biopsy for Colorectal Cancer: A Multicenter Cross-Sectional StudyAtsuhiro Sasaki, Masatake Kuroha, Masaki Tosa, et al.
Pageof 9